Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN267200603423, HHSN267200603424, HHSN267200603426, HHSN275201300023I-HHSN2750008)
Instituto de Salud Carlos III (G03/176)
H2020 European Research Council (268479-BREATHE)
Erasmus Universiteit Rotterdam
Academy of Finland
Spanish Ministry of Health (FIS-PI04/1436, FIS-PI08/1151)
Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (050-060-810)
European Union’s Horizon 2020 (633595)
University of Helsinki Research Funds
Text and Data Mining valid from 2020-04-30
Received: 3 January 2020
Accepted: 15 April 2020
First Online: 30 April 2020
Ethics approval and consent to participate
: IRB approved the EAGeR trial (Salt Lake City, Utah IRB #1002521), and all participants provided written informed consent prior to enrollment. The INMA study was conducted with the approval of the hospital ethics committee, and written informed consent was obtained from all women from INMA cohort located in Sabadell. The Generation R Study has been approved by the Medical Ethical Committee of the Erasmus MC, University Medical Center Rotterdam (MEC 198.782/2001/31). Informed consent was obtained for all participants. The PREDO study protocol was approved by the Ethics Committee of Obstetrics and Gynaecology and Women, Children, and Psychiatry of the Helsinki and Uusimaa Hospital District and by the participating hospitals. All participants provided written informed consent. Consent of participating children was provided by parent(s)/guardian(s).
: All authors contributed to the manuscript and approve its submission.
: The authors report no competing interests.